Furthermore, compared with 3T3-L1s treated with Met, a drug that is widely used for the treatment of T2D, the expression levels of p-IRS and p-AKT in cells treated with 100 μg/mL SP were higher. The gene discussed is AKT1; the disease is type 2 diabetes mellitus.